Cannabinoid CB{sub 1} receptor inhibition decreases vascular smooth muscle migration and proliferation
- Laboratory of Physiological Studies, NIAAA, National Institutes of Health, Section on Oxidative Stress and Tissue Injury, 5625 Fishers Lane, MSC-9413, Bethesda, MD 20892-9413 (United States)
- Department of Surgery, UMDNJ-New Jersey Medical School, Newark, NJ 07103 (United States)
Vascular smooth muscle proliferation and migration triggered by inflammatory stimuli and chemoattractants such as platelet-derived growth factor (PDGF) are key events in the development and progression of atherosclerosis and restenosis. Cannabinoids may modulate cell proliferation and migration in various cell types through cannabinoid receptors. Here we investigated the effects of CB{sub 1} receptor antagonist rimonabant (SR141716A), which has recently been shown to have anti-atherosclerotic effects both in mice and humans, on PDGF-induced proliferation, migration, and signal transduction of human coronary artery smooth muscle cells (HCASMCs). PDGF induced Ras and ERK 1/2 activation, while increasing proliferation and migration of HCASMCs, which were dose dependently attenuated by CB{sub 1} antagonist, rimonabant. These findings suggest that in addition to improving plasma lipid alterations and decreasing inflammatory cell migration and inflammatory response, CB{sub 1} antagonists may exert beneficial effects in atherosclerosis and restenosis by decreasing vascular smooth muscle proliferation and migration.
- OSTI ID:
- 21255812
- Journal Information:
- Biochemical and Biophysical Research Communications, Vol. 377, Issue 4; Other Information: DOI: 10.1016/j.bbrc.2008.10.159; PII: S0006-291X(08)02136-0; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation
The inhibitory effect of dexamethasone on platelet-derived growth factor-induced vascular smooth muscle cell migration through up-regulating PGC-1{alpha} expression